Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GenovaTSE:9341 -0.97%77 Days Payable is 23.40 as of Mar. 2026, which is 15% below its 10-year median of 27.43. GuruFocus rates TSE:9341 with a GF Score™ of 77/100 and a GF Value™ of 円1,961.82 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Genova ranks worse than 91.7% on this metric.
Genova's average Accounts Payable for the
six
months ended in Mar. 2026 was 円396 Mil. Genova's Cost of Goods Sold for the
six
months ended in Mar. 2026 was 円3,085 Mil.
Hence, Genova's Days Payable for the
six
months ended in Mar. 2026 was 23.40.
The historical rank and industry rank for Genova's Days Payable or its related term are showing as below:
TSE:9341'
s Days Payable Range Over the Past 10 Years
Min: 22.22 Med: 27.43 Max: 28.56
Current: 22.72
During the past 6 years, Genova's highest Days Payable was 28.56. The lowest was 22.22. And the median was 27.43.
TSE:9341's Days Payable is ranked worse than 91.7% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs TSE:9341: 22.72
Genova's Days Payable
increased
from Mar. 2025 (19.69) to Mar. 2026 (23.40).
It may suggest that Genovadelayed paying its suppliers.
Genova Days Payable Related Terms
Genova Days Payable Historical Data
* Premium members only.
The historical data trend for Genova's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:9341 vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Genova's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genova Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Genova's Days Payable distribution charts can be found below:
* The bar in red indicates where Genova's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Genova's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genova (TSE:9341) has a Days Payable of 23.40 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Genova and its competitors. This is 15% below median its historical median of 27.43. Over the past decade, Genova's Days Payable has ranged from 22.22 to 28.56. According to the industry distribution chart, Genova ranks #729 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 91.7%.
Is Genova's Days Payable too high?
Genova's current Days Payable of 23.40 is 15% below median its 10-year median of 27.43. Over the past 10 years, this metric has ranged from a low of 22.22 to a high of 28.56. The Medical Devices & Instruments industry median Days Payable is 67.87. Genova's value of 23.40 is 65.5% below this industry median. Based on the distribution chart, Genova ranks #729 out of 795 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Genova has a GF Score™ of 77/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Genova's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Genova ranks #729 out of 795 companies for Days Payable. This places Genova in the lower half of its industry. The industry median Days Payable is 67.87. Genova's value of 23.40 is 65.5% below this benchmark. Historically, Genova's own Days Payable has ranged from 22.22 to 28.56 over the past decade. While the company's 10-year median is 27.43 vs. the industry median of 67.87, Genova has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Genova's current Days Payable of 23.40 is 65.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Genova and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genova's current Days Payable is 23.40, which is 15% below median its own 10-year median of 27.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genova stock overvalued right now?
Based on GuruFocus' analysis, Genova (TSE:9341) is currently considered Possible Value Trap. The stock's GF Value™ is 円1,961.82, compared to a current price of 円611.00 — trading 68.9% below its estimated fair value. The current Days Payable is 23.40, which is 15% below median its 10-year median of 27.43 and 65.5% below the Medical Devices & Instruments industry median of 67.87. Genova's overall GF Score™ is 77/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Genova (TSE:9341), the current Days Payable is 23.40 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Genova (TSE:9341) Overvalued in 2026?
Based on GuruFocus' analysis, Genova stock appears to be undervalued.
The current stock price of 円611.00 is trading 68.9% below its estimated GF Value™ of 円1,961.82.
GuruFocus considers Genova to be Possible Value Trap.
Key valuation signals for TSE:9341:
Days Payable: 23.40 (15% below median its 10-year median of 27.43)
GF Value™: 円1,961.82 vs. price of 円611.00 (68.9% below fair value)
Industry Position: 65.5% below the Medical Devices & Instruments median (#729 of 795)
No single metric tells the full story. See the TSE:9341 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Genova Inc manages operations of the medical information site and sales of automatic reception and payment machines for clinics. The group operates in two reportable segments: Medical Platform Business and the Smart Clinic Project. The majority of its revenue is generated from the Medical Platform Business, which operates an online media site (Medical Dock) that provides preventive information and health knowledge to users (patients) on diseases and symptoms. In addition, it also supports users in finding a family doctor that suits them. The Smart Clinic Business develops and provides services that improve the convenience and efficiency of non-medical procedures at medical institutions.
77GF Score
Get the complete analysis for TSE:9341
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9341 has been successfully added to your 
